Charlotte Barker - Concepedia

Author

Charlotte Barker

Also Known As

C I S Barker, C. Barker, C.I.S. Barker, Charlotte Barker, Charlotte I Barker, Charlotte I S Barker, Charlotte I. Barker, Charlotte I. S. Barker, Charlotte I.S. Barker, G Pek

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University College London St George's, University of London Great Ormond Street Hospital University of Tartu St George’s University Hospitals NHS Foundation Trust

About

Charlotte Barker is an author at University College London specializing in medicine, pharmacokinetics, and pharmacokinetic modeling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	287
2	Biostatistics	1	1	31
3	Critical Care Medicine	1	1	80
4	Microbiology	1	1	37
5	Nephrology	1	1	80

Charlotte Barker

Publications

476

Citations

H-Index

Page 1

	Year	Citations
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful? Eva Germovsek, Charlotte Barker, Mike Sharland, British Journal of Clinical Pharmacology	2016	129
What do I need to know about aminoglycoside antibiotics? Eva Germovsek, Charlotte Barker, Mike Sharland Archives of Disease in Childhood Education & Practice Therapeutic Drug MonitoringAntibioticsMedicineGram-negative PathogensPeak Concentration	2016	100
Augmented Renal Clearance Implies a Need for Increased Amoxicillin-Clavulanic Acid Dosing in Critically Ill Children Pieter De Cock, Joseph F. Standing, Charlotte Barker, Antimicrobial Agents and Chemotherapy Physiologically-based Pharmacokinetic ModelingPharmacokineticsAmoxicillin ClearanceCritical Care MedicineCritically Ill Children	2015	80
Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design Karin Kipper, Charlotte Barker, Joseph F. Standing, Antimicrobial Agents and Chemotherapy Novel Multipenicillin AssayAntibiotic AdjuvantAntimicrobial ChemotherapyPharmacodynamic ModelingAnalyte Degradation	2017	37
Utilization of Data Below the Analytical Limit of Quantitation in Pharmacokinetic Analysis and Modeling: Promoting Interdisciplinary Debate Max Hecht, Rūta Veigure, Lewis Couchman, Bioanalysis Drug AnalysisPharmacokinetic ModelingPharmacodynamicsData BelowPharmacometrics	2018	31
β-Lactam antimicrobial pharmacokinetics and target attainment in critically ill patients aged 1 day to 90 years: the ABDose study D Lonsdale, Karin Kipper, Emma H. Baker, Journal of Antimicrobial Chemotherapy	2020	26
Not too little, not too much: problems of selecting oral antibiotic dose for children Julia Bielicki, Charlotte Barker, Sonia Saxena, BMJ Oral Antibiotic DoseResistant PathogensAntimicrobial ChemotherapyAntibiotic ResistancePharmacodynamic Modeling	2015	25
Pharmacokinetics of Penicillin G in Preterm and Term Neonates Helgi Padari, Tuuli Metsvaht, Eva Germovsek, Antimicrobial Agents and Chemotherapy	2018	22
Medical resource use in a phase III trial (SO 14796) of XelodaTM (capecitabine) in previously untreated advanced/metastatic colorectal cancer Chris Twelves, Eric Van Cutsem, K Hieke, European Journal of Cancer Advanced/metastatic Colorectal CancerOncologyCancer ManagementPhase Iii TrialColorectal Cancer	1999	14
Oral penicillin prescribing for children in the UK: a comparison with<i>BNF for Children</i>age-band recommendations Sonia Saxena, Zareen Ismael, Macey L. Murray, British Journal of General Practice	2014	12

Page 1